Can people with cardiomyopathy eat spicy food?

Written by Liu Yong
Cardiology
Updated on September 22, 2024
00:00
00:00

Generally speaking, patients with cardiomyopathy during stable phases may consider consuming spicy food, especially since these patients often have relatively poor appetites. Using mildly spicy food can potentially stimulate the appetite and improve nutritional status. However, from another perspective, excessive consumption of spicy food may cause patients to drink large amounts of water. Excessive intake could potentially increase the burden on cardiac function; therefore, it is not recommended for patients with cardiomyopathy to consume overly spicy foods. Patients with cardiomyopathy also have dietary restrictions, including a diet low in salt and fat, as overly salty diets can also exacerbate the burden on the heart and kidneys.

Other Voices

doctor image
home-news-image
Written by Liu Yong
Cardiology
1min 53sec home-news-image

Does cardiomyopathy require surgery?

Firstly, whether myocardial disease requires surgery, we need to clarify the type of myocardial disease and the stage of myocardial disease, that is, the stage of heart function that has been affected. There are many types of myocardial diseases, including dilated cardiomyopathy, ischemic cardiomyopathy, and restrictive cardiomyopathy, for instance. The treatment plans for different types of myocardial diseases are not exactly the same. For example, dilated cardiomyopathy is generally treated with medication, and only in the very late stages of dilated cardiomyopathy, or what is known as stage IV heart function, when conventional medication is ineffective, heart transplantation might be considered if a donor is available and conditions allow. However, currently, heart donors are extremely rare, making this option quite difficult to achieve. The latest advances in clinical research have introduced artificial mechanical hearts available for transplantation, but the costs of surgery are very high, and the technology is not very mature yet. Therefore, the chances and opportunities for surgery are not very great and must be decided based on the situation. For other conditions, such as ischemic cardiomyopathy, if it is clearly caused by severe ischemia, we might consider addressing the factors causing myocardial ischemia, such as performing a coronary angiography. If there is severe coronary artery stenosis, we might consider implementing a coronary artery stent or coronary artery bypass grafting to alleviate the ischemic factors. In cases like restrictive cardiomyopathy, if there are severe restrictive factors contributing to the disease, surgical treatment might also be pursued.

doctor image
home-news-image
Written by Li Hai Wen
Cardiology
51sec home-news-image

What should I do if dilated cardiomyopathy is causing insomnia?

Dilated cardiomyopathy causing insomnia needs to be treated based on the cause of the insomnia. First, if it is simply poor sleep quality causing occasional insomnia, no special treatment is needed. However, if insomnia occurs daily and affects quality of life, sleep-improving medications such as eszopiclone or zopiclone may be taken under a doctor's guidance. Second, if caused by worsening heart failure symptoms, which lead to nocturnal respiratory distress and affect sleep, resulting in insomnia, the treatment for heart failure should be intensified under a doctor's guidance, for instance, by increasing diuretic treatment or adjusting medications. Improving heart failure symptoms naturally enhances sleep quality. (If medication is required, please do so under the guidance of a doctor)

doctor image
home-news-image
Written by Tang Li
Cardiology
1min 38sec home-news-image

How is hypertrophic cardiomyopathy treated?

The treatment of hypertrophic cardiomyopathy aims to improve symptoms, reduce complications, and prevent sudden death. The methods include improving ventricular compliance by reducing outflow tract obstruction, preventing thromboembolic events, and identifying high-risk patients for sudden death. Treatment needs to be individualized, and the main treatments include the following aspects: 1. Medication treatment. Drug treatment is fundamental, and drugs targeting outflow tract obstruction mainly include receptor blockers and non-dihydropyridine calcium channel blockers. For patients with congestive heart failure, targeted treatment is required. Anticoagulation treatment is necessary for patients with atrial fibrillation, and it is worth noting that for patients with chest discomfort, care should be taken to exclude outflow tract obstruction when using nitrate drugs to avoid exacerbation after use. Non-drug treatments include: 1. Surgical treatment: For patients with ineffective drug treatment and heart function class three to four, if there is severe outflow tract obstruction, septal myectomy should be considered. Currently, surgery is listed as the preferred treatment for suitable patients in consensus guidelines in both America and Europe. 2. Alcohol septal ablation; 3. Pacing therapy.

doctor image
home-news-image
Written by Zhang Yue Mei
Cardiology
1min home-news-image

What department should I register for cardiomyopathy?

Myocardial disease is a common and frequently occurring disease in clinical practice, caused by various reasons leading to pathological changes in the myocardium. Common causes include viral infections, immune system disorders, and other factors, which can lead to degeneration, necrosis, fibrosis, and interstitial edema of the myocardium. This can cause heart failure, arrhythmias, and in severe cases, even death. Therefore, early diagnosis and timely treatment can save patients' lives and alleviate their suffering. It is necessary to consult with a psychiatrist, undergo relevant examinations under the guidance of a psychiatrist, make a clear diagnosis, and actively treat and rescue the patients.

doctor image
home-news-image
Written by Tang Li
Cardiology
1min 14sec home-news-image

What is the prognosis of hypertrophic cardiomyopathy?

The prognosis of hypertrophic cardiomyopathy varies greatly, and it is the primary cause of sudden death in adolescents and athletes because it can progress to end-stage heart failure. Additionally, a small percentage may experience heart failure, atrial fibrillation, and embolism, but many patients have mild symptoms and can have a life expectancy close to normal. For the treatment of hypertrophic cardiomyopathy, adequate sudden death risk assessment and ICD prevention should be conducted. Because hypertrophic cardiomyopathy is the most common cause of sudden cardiac death in young people and athletes, an ICD can effectively prevent the occurrence of sudden death. Preventing high-risk factors, including previous cardiac arrest, one or more sudden deaths in first-degree relatives, severe left ventricular hypertrophy, and findings of repetitive non-sustained ventricular tachycardia on a 24-hour Holter monitor, low blood pressure during exercise, and unexplained syncope, especially during exercise, poses a high risk of sudden death in these patients.